Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KG
5851
Kestrel Group
KG
$61.7M
| $34K | ﹤0.01% |
797
+796
| +79,600% | +$34K |
|
5852
Playboy Inc
PLBY
$151M
| $34K | ﹤0.01% |
20,309
-4,866
| -19% | -$8.22K |
|
5853
SES AI
SES
$223M
| $34K | ﹤0.01% |
13,854
+12,083
| +682% | +$23.4K |
|
5854
Entrada Therapeutics
TRDA
$290M
| $34K | ﹤0.01% |
+2,233
| New | +$30.8K |
|
5855
Simplify Short Term Treasury Futures Strategy ETF
TUA
$661M
| $34K | ﹤0.01% |
+1,505
| New | +$36.9K |
|
5856
Universal Logistics Holdings
ULH
$509M
| $34K | ﹤0.01% |
1,207
+294
| +32% | +$8.14K |
|
|
VRNA
5857
DELISTED
Verona Pharma
VRNA
| $34K | ﹤0.01% |
1,575
-167
| -10% | -$3.56K |
|
5858
Global Water Resources
GWRS
$247M
| $33K | ﹤0.01% |
2,630
-57
| -2% | -$674 |
|
|
VIGL
5859
DELISTED
Vigil Neuroscience
VIGL
| $33K | ﹤0.01% |
+3,499
| New | +$33.1K |
|
5860
Zevra Therapeutics
ZVRA
$672M
| $33K | ﹤0.01% |
6,552
+5,365
| +452% | +$28.9K |
|
|
ICPT
5861
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $33K | ﹤0.01% |
2,965
-5,413
| -65% | -$75.4K |
|
|
ALLK
5862
DELISTED
Allakos
ALLK
| $32K | ﹤0.01% |
7,299
+7,291
| +91,138% | +$32.8K |
|
5863
Accuray
ARAY
$33.2M
| $32K | ﹤0.01% |
8,343
+5,969
| +251% | +$20.7K |
|
|
STEX
5864
Streamex Corp
STEX
$108M
| $32K | ﹤0.01% |
2,470
+1,770
| +253% | +$22.6K |
|
5865
Daktronics
DAKT
$986M
| $32K | ﹤0.01% |
4,982
+4,561
| +1,083% | +$26.8K |
|
5866
First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF
FCEF
$82.7M
| $32K | ﹤0.01% |
1,661
-12,347
| -88% | -$236K |
|
5867
Farmers & Merchants Bancorp
FMAO
$483M
| $32K | ﹤0.01% |
1,417
+367
| +35% | +$8.07K |
|
5868
Five Star Bancorp
FSBC
$1.15B
| $32K | ﹤0.01% |
1,431
-14
| -1% | -$284 |
|
5869
MacroGenics
MGNX
$268M
| $32K | ﹤0.01% |
5,922
+2,153
| +57% | +$13.3K |
|
5870
NET Power
NPWR
$172M
| $32K | ﹤0.01% |
2,439
| – | – |
|
|
OPRA
5871
Opera Ltd
OPRA
$1.82B
| $32K | ﹤0.01% |
+1,633
| New | +$23.3K |
|
5872
Oric Pharmaceuticals
ORIC
$1.44B
| $32K | ﹤0.01% |
4,071
+4,065
| +67,750% | +$23.1K |
|
5873
SKYX Platforms
SKYX
$151M
| $32K | ﹤0.01% |
11,913
+11,201
| +1,573% | +$36K |
|
5874
Stoke Therapeutics
STOK
$2.02B
| $32K | ﹤0.01% |
2,959
+1,617
| +120% | +$17.2K |
|
5875
Wave Life Sciences
WVE
$1.07B
| $32K | ﹤0.01% |
8,787
+6,332
| +258% | +$25.6K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 675 new, 3,796 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 675 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.